To our knowledge, no population-based studies have been performed to examine these potential risks. Importance Current studies assessing the risk of stroke, myocardial infarction (MI), and death in patients undergoing intravitreal anti–vascular endothelial growth factor (VEGF) therapy are inconclusive. Shared Decision Making and Communication.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |